Supplementary Figure S2 : Individual siRNAs A, B and D were able to down-regulate NKX2-1-AS1 expression by >80% in H441 cells, similar to the combination of all three siRNAs used in the experiments in this study, which was used to reduce non-specific effects of individual siRNAs. NKX2-1 mRNA expression was not significantly changed by NKX2-1-AS1 knockdown with any of the individual siRNAs. Treatment with individual siRNAs (A, B, or D) significantly increased expression of CD274, and treatment with B or D significantly increased expression of PTPN1, both genes identified as downstream of NKX2-1-AS1 in this study. n=3; ** p< 0.01; ***p< 0.001.
Supplementary Figure S2
Supplementary Figure S3 : Knockdown of NKX2-1-AS1 in H661 using the mix of 3 siRNAs had no effect on the expression of neighboring genes. As was observed in H441 cells, downregulation of NKX2-1-AS1 > 90% at 48h did not significantly change the levels of NKX2-1 and NKX2-8. Unlike in H441 cells, however, down-regulation of NKX2-1-AS1 did not affect PAX9 levels. n=3; * p<0.05.
Supplementary Figure S3
Supplementary Figure S4 (A) Overexpression of NKX2-1-AS1 in H441 cells showed no effect on the levels of expression of NKX2-1 (n=3, *p<0.05). (B) Overexpression of NKX2-1 in H441 cells did not affect expression of NKX2-1-AS1 or PAX9 but increased transcription of its known target gene SFTPC (n=3; *p < 0.05). 
Supplementary Figure S4

NAME
Assay ID number/sequence NKX2-1 AS1 AJHSOEQ Custom Thermo Fisher Target chr14:36988483-36992221 GRCh38 139bp and Hs04408121_m1
NKX2-1 both variants
Hs00968940_m1 NKX2-1 single variant Hs03968940_m1 MBIP Hs00968947_m1 SFTPC Hs00161628_m1 SLC25A21 Hs00229049_m1 PTPN1 Hs00942477_m1 MET Hs00179845_m1 FARP2 Hs00919572_m1 SNAI2 Hs00161904_m1 CLDN1 Hs00221623_m1 FGFBP1 Hs01921428_s1 RBPJ Hs00794653_m1 CD274 Hs00204257_m1
NKX2-1AS1 Copy #1
AJ6RN26 Custom Thermo Fisher Target chr14:36990354-36990848 (GRCh38) 96bp 
Positive control gene expression
The expression of several constitutively expressed Y-linked genes (DDX3Y, KDM5D, RPS4Y1, USP9Y, and UTY) was assessed to estimate the dynamic range of the array, as these genes will serve as strong positive or negative expression controls in males and females, respectively. In both experiments the expression of XIST was very low (~1-2 log2 units) in all samples, and although the expression of most Y-linked genes was also relatively low (~2-4 log2 units), the DDX3Y had moderate expression (~5 log2 units) in all samples across both experiments. These findings are in agreement with the fact that the H441 cell line was derived from a male subject and contains a Y chromosome (http://www.atcc.org/products/all/HTB-174.aspx). As other housekeeping genes had high expression, there appears to be good dynamic range to discriminate true positive and negative controls in this experiment.
The expression of NKX2-1-AS1 was decreased ~1.2-fold in the knockdown group versus the control group in both experiments (reduction to 83% of original levels in Experiment 1 and 81% of original levels in Experiment 2).
Principal Component Analysis (PCA)
Following the initial QC analysis, Principal Component Analysis (PCA) was performed. PCA is a mathematical transform that collapses the variance between samples across a set of large set of variables (here, all ~25,000 genes on the array) into a much smaller set of variables called Principal Components (PCs). These "meta-variables" are arranged such that PC1 explains the most variance in the data, followed by PC2, etc.
PCA was performed using all genes across all samples, and a plot was made of PC2 vs. PC1 for both experiments independently and then combined. The plots can also be downloaded at: 2014-08-08_Ramirez_combined_PCA.pdf Figure 1 . PCA analysis of combined samples from Experiments 1 and 2, unadjusted for experimental protocol.
Samples shown in Figure 1 separate on the PCA plot by experiment along the PC1 axis, which explains 28% of variance in the experiment. This suggests that either the RNA extraction protocol or batch effect is the major cause of variance between the two experiments. However, in both experimental groups, control samples separate well from the NKX2-1-AS1 knockdown samples along the PC2 axis, which explains 11% of the variance in the experiment, suggesting that the siNKX2-1-AS1 treatment caused the most variance within each experiment. Figure 2 shows the adjustment for experimental protocol leading to a distinct separation between all of the control and all of the NKX2-1-AS1 knockdown samples from both experiments along the PC1 axis, which is responsible for 16% of variance in the experiment. However, in both the control samples and the ABD clusters, the distinct experimental groups separate from each other. This suggests that after adjusting for experimental protocols, the treatment becomes the most important cause in variance across all samples, and the separation between the experimental groups may potentially be explained by the two different RNA extraction methods.
Moderated t tests: NKX2-1-AS1 knockdown versus control
To identify genes whose expression changed with respect to treatment after adjusting for experimental protocol, a linear model was created of the form expression ~ protocol + treatment where '~' means 'is a function of', and protocol and treatment are treated as categorical variables. The treatment effect therefore measures whether a given gene changes expression between siRNA groups after correcting for any technical effects introduced by the two experiments.
A t test was then performed for the treatment term in the model to determine its significance. A "moderated" t test was used, which is a Bayesian analysis that does not test each gene independently, but rather, leverages information from all of the genes on the array to increase statistical power over a standard two-sample Student t test. It is especially helpful when sample sizes are small.
Benjamini-Hochberg False Discovery Rate (FDR) correction was then applied to obtain FDR-corrected p values ('q' values), which represent the probability that a given result is a false positive based on the distribution of all p values on the array. Corrected/adjusted p values such as the FDR q are the best measure of significance for a given test when many hypotheses (e.g., ~25,000 genes) are tested at once. In addition, the FDR q value was also recomputed after removing probesets that were not expressed above the array-wise median value of at least one array. Probesets with low overall expression are more strongly affected by random technical variation and more likely to produce false positive results. As was expected, when combining all samples from the two experiments and adjusting for experimental protocols, there are considerable differential gene expressions changes between the cells treated with NKX2-1-AS1 siRNA and control siRNA. This is further reflected in the large number of genes that pass FDR q correction.
